Clinical Trials Browser

Phase 1 × Has results × peginterferon alfa-2b × Clear all

NCT02948426 2026-01-08

Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Phase 1 Terminated

18 enrolled 19 charts

Carcinoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03554005 2019-07-15

MK-4031-009

Phase 1 Completed

29 enrolled 11 charts

Neoplasms

NCT00457418 2017-06-07

High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)

Phase 1 Completed

32 enrolled 12 charts

Melanoma

NCT01496807 2017-04-28

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Phase 1 Completed

31 enrolled 11 charts

Melanoma

NCT00589550 2015-06-08

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 1 Terminated

1 enrolled 2 charts

Carcinoma, Renal Cell, Kidney Neoplasms